3.30 MB - Academy of Medicine of Malaysia
3.30 MB - Academy of Medicine of Malaysia
3.30 MB - Academy of Medicine of Malaysia
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
MANAGEMENT OF HIV INFECTION IN CHILDREN<br />
73 O'Brien RJ & Perriens JH. Preventive therapy for tuberculosis in HIV infection: the<br />
promise and the reality. AIDS. 1995 Jul;9(7):665-673.<br />
74 Hesseling AC, Schaaf HS, Gie RP, et al. A critical review <strong>of</strong> diagnostic approaches used in<br />
the diagnosis <strong>of</strong> childhood tuberculosis. Int J Tuberc Lung Dis. 2002 Dec;6(12):1038-1045.<br />
75 H<strong>of</strong>stadler G, Schmitt K, Tulzer G et al . BCG lymphadenitis in an HIV-infected child 9.5<br />
years after vaccination. AIDS Patient Care STDS. 1998 Sep;12(9):677-680.<br />
76 Rosenfeldt V, Paerregaard A & Valerius NH. Disseminated infection with Bacillus Calmette-Guerin<br />
in a child with advanced HIV disease. Scand J Infect Dis. 1997;29(5):526-527.<br />
77 Bhat GJ, Diwan VK, Chintu C et al. Related Articles, HIV, BCG and TB in children: a case<br />
control study in Lusaka, Zambia. J Trop Pediatr. 1993 Aug;39(4):219-223.<br />
78 Marsh BJ, Von Reyn CF, Edwards J. The risks and benefits <strong>of</strong> childhood bacille Calmette-Guerin<br />
immunization among adults with AIDS. International MAC study groups. AIDS.<br />
1997;11:669-672.<br />
79 Arbelaez MP, Nelson KE, Munoz A. Related Articles, BCG vaccine effectiveness in<br />
preventing tuberculosis and its interaction with human immunodeficiency virus infection.<br />
Int J Epidemiol. 2000 Dec;29(6):1085-1091.<br />
80 Ion-Nedelcu N, Dobrescu A, Strebel PM, et al. Vaccine-associated paralytic poliomyelitis<br />
and HIV infection. Lancet. 1994 Jan 1;343(8888):51-52.<br />
81 Chitsike I, Van Furth R. Paralytic poliomyelitis associated with live oral poliomyelitis<br />
vaccine in child with HIV infection in Zimbabwe: case report. BMJ. 1999 Mar<br />
27;318(7187):841-843.<br />
82 Barbi M, Biffi MR, Binda S, Clerici-Schoeller M, Ferraris G, Luraschi C, et al . Immunization<br />
in children with HIV seropositivity at birth: antibody response to polio vaccine and tetanus<br />
toxoid. AIDS. 1992 Dec;6(12):1465-1469.<br />
83 Lepage P, Dabis F, Msellati P, et al. Safety and immunogenicity <strong>of</strong> high-dose Edmonston-<br />
Zagreb measles vaccine in children with HIV-1 infection. A cohort study in Kigali, Rwanda.<br />
Am J Dis Child. 1992;146:550-555.<br />
84 Krasinski K, Borkowsky W. Measles and measles immunity in children infected with human<br />
immunodeficiency virus. JAMA. 1989 May 5;261(17):2512-2516.<br />
85 Thaithumyanon P, Punnahitananda S, Thisyakorn U, et al. Immune responses to measles<br />
immunization and the impacts on HIV-infected children. Southeast Asian J Trop Med Public<br />
Health. 2000 Dec;31(4):658-662.<br />
86 Lima M, De Menezes Succi RC, Nunes Dos Santos AM. Rubella immunization in human<br />
immunodeficiency virus type 1-infected children: cause for concern in vaccination<br />
strategies. Pediatr Infect Dis J. 2004;23:604-607.<br />
87 Aurpibul L, Puthanakit T, Siriaksorn S, et al. Prevalence <strong>of</strong> protective antibody against<br />
measles in HIV-infected children with immune recovery after highly active antiretroviral<br />
therapy.HIV Med. 2006 Oct;7(7):467-470.<br />
88 Centers for Disease Control and Prevention. Prevention <strong>of</strong> varicella, recommendations <strong>of</strong><br />
the Advisory Committee on Immunization Practices (ACIP), MMWR Recomm Rep<br />
1996;45(RR-11):1-36.<br />
58
Change language